XORTX Therapeutics Inc. Skyrocketed
Thu, Aug 29, 2024 at 07:41 PM
XORTX Therapeutics Inc. (XRTX:NASDAQ) soared at $2.7, representing a gain of 130.8%. On Thu, Aug 29, 2024, XRTX:NASDAQ hit a New 2-Week High of $2.7. The stock got featured on our News Catalysts scanner on Thu, Aug 22, 2024 at 04:47 AM in the 'MISCELLANEOUS' category. From Thu, Aug 15, 2024, the stock recorded 30.00% Up Days and 36.36% Green Days
About XORTX Therapeutics Inc. (XRTX:NASDAQ)
XORTX Therapeutics Inc is focused on developing drug therapies for orphan disease like polycystic kidney disease, and treatment of health consequences caused by chronic high serum uric acid which...
Top 10 Gainers:
- XORTX Therapeutics Inc. (XRTX:NASDAQ), 130.77%
- Calithera Biosciences, Inc. (CALA:NASDAQ), 60%
- Innovative Eyewear Inc. (LUCY:NASDAQ), 53.78%
- Movella Holdings Inc Com (MVLA:NASDAQ), 49%
- Singularity Future Technology Ltd. (SGLY:NASDAQ), 39.86%
- Raytech Holding Limited (RAY:NASDAQ), 38.67%
- Theriva Biologics Inc Com Par $.001 (TOVX:NYSEMKT), 34.29%
- ARCA biopharma, Inc. (ABIO:NASDAQ), 32.49%
- Affirm Holdings Inc. (AFRM:NASDAQ), 31.92%
- TC BioPharm (Holdings) plc (TCBP:NASDAQ), 30.24%